Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prostatic Ductal Adenocarcinoma Controlled for Cancer Grade and Tumor Volume Does Not Have an Independent Effect on Adverse Radical Prostatectomy Outcomes Compared to Usual Acinar Prostatic Adenocarcinoma.
Iakymenko OA, Lugo I, Kwon D, Zhao W, Hayee A, Punnen S, Parekh DJ, Pollack A, Ritch CR, Gonzalgo ML, Stoyanova R, Jorda M, Kryvenko ON. Iakymenko OA, et al. Among authors: lugo i. Urology. 2020 Mar;137:108-114. doi: 10.1016/j.urology.2019.10.014. Epub 2019 Nov 9. Urology. 2020. PMID: 31711982 Free PMC article.
Percentage of Gleason pattern 4 and tumor volume predict adverse pathological stage and margin status at radical prostatectomy in grade Group 2 and grade Group 3 prostate cancers.
Iakymenko OA, Lugo I, Briski LM, Nemov I, Punnen S, Kwon D, Pollack A, Stoyanova R, Parekh DJ, Jorda M, Gonzalgo ML, Kryvenko ON. Iakymenko OA, et al. Among authors: lugo i. Prostate. 2021 Sep;81(12):866-873. doi: 10.1002/pros.24183. Epub 2021 Jun 29. Prostate. 2021. PMID: 34184782
Anterior or Posterior Prostate Cancer Tumor Nodule Location Predicts Likelihood of Certain Adverse Outcomes at Radical Prostatectomy.
Hayee A, Lugo I, Iakymenko OA, Kwon D, Briski LM, Zhao W, Nemov I, Punnen S, Ritch CR, Pollack A, Jorda M, Stoyanova R, Parekh DJ, Gonzalgo ML, Kryvenko ON. Hayee A, et al. Among authors: lugo i. Arch Pathol Lab Med. 2022 Jul 1;146(7):833-839. doi: 10.5858/arpa.2021-0104-OA. Arch Pathol Lab Med. 2022. PMID: 34669939 Free article.
Prostatic Ductal Adenocarcinoma Controlled for Tumor Grade, Stage, and Margin Status Does Not Independently Influence the Likelihood of Biochemical Recurrence in Localized Prostate Cancer After Radical Prostatectomy.
Kryvenko ON, Iakymenko OA, De Lima Guido LP, Bhattu AS, Merhe A, Mouzannar A, Briski LM, Oymagil I, Lugo I, Nemov I, Ritch CR, Kava BR, Punnen S, Jorda M, Parekh DJ, Gonzalgo ML. Kryvenko ON, et al. Among authors: lugo i. Arch Pathol Lab Med. 2022 Aug 1;146(8):1012-1017. doi: 10.5858/arpa.2021-0048-OA. Arch Pathol Lab Med. 2022. PMID: 34739539 Free article.
Comment on: Personalized Model to Predict Keratoconus Progression From Demographic, Topographic, and Genetic Data.
Gatinel D, Tello A, Niño CA, Translateur A, Lugo IK, Berrospi RD, Tello A, Niño CA, Translateur A, Lugo IK, Berrospi RD, Tello A, Niño CA, Berrospi RD. Gatinel D, et al. Among authors: lugo ik. Am J Ophthalmol. 2023 May;249:191-192. doi: 10.1016/j.ajo.2022.10.025. Epub 2022 Nov 12. Am J Ophthalmol. 2023. PMID: 36379321 No abstract available.
Measures to evaluate quality of care in renal cancer: results of a Delphi study in Spain.
Guillem Porta V, Camps C, Climent Durán MÁ, Gallardo E, González Del Alba A, Lázaro-Quintela M, Méndez Vidal MJ, Pinto Marín Á, Puente J, Antón-Rodríguez C, Caballero-Martínez F, Campos-Lucas FJ, Lugo I, Rogado Á, Durán I. Guillem Porta V, et al. Among authors: lugo i. Clin Transl Oncol. 2022 Mar;24(3):495-502. doi: 10.1007/s12094-021-02703-9. Epub 2021 Sep 5. Clin Transl Oncol. 2022. PMID: 34482526
19 results